GBA Presents: House of Gummy-!

stonedinvestor said:
AAPL Apple Inc. -- I have $170 & $166 as support/ will not go below $166 I do not think. Leg into this: buy 1/3 now.

$173.98-5.68 (-3.16%)10:31 AM 03/04/24
NASDAQ | $USD | Real
More...



GBA: we have two lots and an average C/B of $172.

GBA SELL--->AAPL Apple Inc. $172--------->$215******
Consecutive win No 58 :wtf:


$215.48 +8.33 (+4.02%)10:46 AM 06/12/24
NASDAQ | $USD | Realtime
 
TrailerParkTed said:
I trade GME usually daily to feel the tape, yesterday I exited 10 puts for a loss below. I reversed to the $25-$30 calls. That’s after a freaking insane Apple gain($40) :)


“
GME Put 06/14/24 $24.00 - PUT GME 06/14/24 24 GAMESTOP CORPORATION EXP 06/14/24
Short-term realized gain/loss
Loss of -1.81-1.81
Long-term realized gain/loss
0.000.00”
More...
I was up $800 on GME, tested the waters. Pounded the Apple $210 and Orcl $140c, fun trades.
stonedinvestor said:
GBA: we have two lots and an average C/B of $172.

GBA SELL--->AAPL Apple Inc. $172--------->$215******
Consecutive win No 58 :wtf:


$215.48 +8.33 (+4.02%)10:46 AM 06/12/24
NASDAQ | $USD | Realtime
More...





Flipped 12000 DDC $1.48 out $1.75.
 
GreatCamel said:
I can use new under garments.

$UA
Under Armour Inc $6.66


sc
View attachment 342025
More...


Everything I try takes forever :(. People need new under garments c'mon buy buy
UA Under Armour Inc $6.80 2.48%
 
stonedinvestor said:
Take a peek here-- This stk has been as high as $10. Nuclear fuel stks are getting a big allotment in the budget. Not exactly what these guys do but they have an update coming March 14.
.
NuScale Power Corporation (SMR)-
NYSE - Nasdaq Real Time Price. Currency in USD

3.8400+0.3900(+11.30%)
As of 10:46AM EST.
More...




UPDATE- $8.75 :wtf:
 
With Bio sometimes you buy the event. Not the product./

Little scared but here is where I would go with ANVS- $6.50

So we know the recent news has not been god this is a " save " situation for management. Can they hype this? I would bet yes./// But still this is highly shorted. And I don't think they cpuld say anything that would really dislodge the shorts.

MALVERN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis, Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), today announced that it will host an investor webcast to discuss recent developments and future plans for its lead drug candidate, Buntanetap.

Investor Call Details:

  • Date and Time: June 11, 2024, 4:30pm ET.
Topics to Be Covered:

  • Recent advancements in the development of Buntanetap.
  • Strategic plans for upcoming clinical trials.
  • Overview of the company’s progress and future direction.
 
You must log in or register to reply here.
Back
Top